Health Condition 1: K758- Other specified inflammatory liverdiseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with NAFLD/MASLD with elevated liver enzymes with or without fibrosis 2. Willing to give written consent for the study
Exclusion criteria
Exclusion criteria: 1. Cirrhosis 2. Presence of other etiologies for fatty liver, eg alcohol, drugs, viral infections, autoimmune hepatitis 3. Uncontrolled diabetes 4. BMI greater than 35 5. AST or ALT greater than 5 times normal 6. Patients on Vit E, Saraglitazor, SGLT-2 7. Patients on Pioglitazone 8. Patients planned for Bariatric surgery or post-bariatric surgery 9. Planned for endoscopic interventions 10. Patients on bile acid chelators/ursodeoxycholic acid/obeticholic acid
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fraction of patients achieving greater than 30% MRI-PDFF change in each arm (responders)Timepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in liver enzymes- AST and ALT 2. Changes in BMI of patients in both arms (at baseline and at end of 1 year) 3. Changes in LSM, and CAP on Fibroscan 4. Insulin resistance and lipid profile Timepoint: 1. 1 year 2. 1 year 3. 1 year 4. 1 year | — |
Countries
India
Contacts
All India Institute of medical Sciences